The 2025 Outstanding Biotechnology Industry Awards have been announced, with 15 companies including Shida, Youlin, and Hankan winning.

The Taiwan Biotechnology Industry Development Association announced the winners of the "2025 Taiwan BIO Awards" on the 8th. Fifteen institutions and product technologies, including Shida, Youlin, and Hankan, stood out, showcasing the outstanding achievements of Taiwan's biotech industry in innovation, research and development, and international competitiveness.

The Gold Award for Outstanding Biotechnology Industry was awarded to Shida and Grape King. The "Potential Benchmark Award" went to Youlin, Jilong Mix, Yuanchang, Ruici, and Shenghe. The "Outstanding Innovation Award" was won by Hankan, Jieluo, and Fecula Biotech. Additionally, in the "Annual Industry Innovation Award," Yongsheng received recognition for its "Umbilical Cord Blood Stem Cell New Drug REGENECYTE," the Industrial Technology Research Institute for its "Innovative Dual-Target Glaucoma Drug," Juyi Smart for "FaceHeart Vitals," Zhenghan for "Precision-guided Peptide-POPs," and Grape King for "Kang'er Dong Lactic Acid Bacteria Granules."

Chairman Liu Licheng stated that the "Taiwan BIO Awards" is an important annual event organized by the association. This award not only acknowledges companies with outstanding achievements but also aims to discover promising newcomers, inspiring continuous innovation within the industry.

In recent years, the global biotech industry has faced a critical moment of technological transformation and international positioning. Taiwan has demonstrated solid resilience and innovative breakthroughs in this wave. The list of award winners this year reflects the diverse development of Taiwan's industry, including innovative drugs, cell and immunotherapy, regenerative medicine, CRDMO, IVD precision diagnostics, advanced medical devices, medical AI, agricultural biotechnology, and health foods, all showcasing high research and development energy and market potential. This indicates that Taiwan's biotech industry chain has matured and is gradually moving towards internationalization.

Zhang Wenchang, convener of the Biotechnology Industry Awards Committee and an academician at Taipei Medical University, stated that the "Outstanding Biotechnology Industry Award" aims to recognize biotech companies and research institutions with excellent operational performance and high potential. To ensure the professionalism and credibility of the selection process, this year, the awards committee invited 22 experts and scholars from industry, government, academia, and research to form a jury. They conducted rigorous reviews and multiple rounds of discussions based on the selection criteria for each award. Ultimately, 15 institutions and their product technologies emerged as winners of this honor.

The award ceremony will be grandly held during the "BIO Asia–Taiwan Biotechnology Conference" from July 23 to 27, where government leaders will personally present the awards and publicly commend the winners. To enhance the international visibility and industry influence of the winning entities, the conference has specially planned a "Showcase of Outstanding Biotechnology Companies," allowing the award-winning companies to share their success stories and innovative technologies during the main agenda. This initiative aims to promote international exchange and cooperation through the international exhibition platform, further driving continuous improvement and growth in the industry.

More Media Coverage>>https://www.ctee.com.tw/news/20250708701257-430504